Zhejiang Wolwo Bio-Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 9.91%

Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (300357) has an Asset Resilience Ratio of 9.91% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 300357 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥286.82 Million

≈ $41.97 Million USD Cash + Short-term Investments

Total Assets

CN¥2.89 Billion

≈ $423.37 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2014–2024)

This chart shows how Zhejiang Wolwo Bio-Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see balance sheet size of Zhejiang Wolwo Bio-Pharmaceutical Co Ltd.

Liquid Assets Composition Over Time

This chart breaks down Zhejiang Wolwo Bio-Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore 300357 long-term investments to assets to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥286.82 Million	9.91%
Total Liquid Assets	CN¥286.82 Million	9.91%

Asset Resilience Insights

Limited Liquidity: Zhejiang Wolwo Bio-Pharmaceutical Co Ltd maintains only 9.91% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Zhejiang Wolwo Bio-Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Zhejiang Wolwo Bio-Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Pfizer Inc NYSE:PFE	Drug Manufacturers - General	5.33%
AbbVie Inc NYSE:ABBV	Drug Manufacturers - General	0.02%
Merck & Company Inc NYSE:MRK	Drug Manufacturers - General	0.22%
AstraZeneca PLC MX:AZNN	Drug Manufacturers - General	0.03%
Novartis AG ADR NYSE:NVS	Drug Manufacturers - General	0.06%
Firebrick Pharma Ltd AU:FRE	Drug Manufacturers - General	0.29%
Eli Lilly and Company SA:LILY34	Drug Manufacturers - General	6.46%
Pfizer Inc SA:PFIZ34	Drug Manufacturers - General	5.33%

Annual Asset Resilience Ratio for Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (2014–2024)

The table below shows the annual Asset Resilience Ratio data for Zhejiang Wolwo Bio-Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	7.24%	CN¥196.09 Million ≈ $28.69 Million	CN¥2.71 Billion ≈ $396.43 Million	+2.66pp
2023-12-31	4.58%	CN¥117.39 Million ≈ $17.18 Million	CN¥2.56 Billion ≈ $374.93 Million	-8.84pp
2022-12-31	13.42%	CN¥295.05 Million ≈ $43.18 Million	CN¥2.20 Billion ≈ $321.62 Million	-5.78pp
2021-12-31	19.20%	CN¥370.93 Million ≈ $54.28 Million	CN¥1.93 Billion ≈ $282.71 Million	+0.07pp
2020-12-31	19.13%	CN¥307.03 Million ≈ $44.93 Million	CN¥1.60 Billion ≈ $234.83 Million	+16.24pp
2019-12-31	2.90%	CN¥41.37 Million ≈ $6.05 Million	CN¥1.43 Billion ≈ $208.99 Million	-8.07pp
2018-12-31	10.97%	CN¥116.00 Million ≈ $16.97 Million	CN¥1.06 Billion ≈ $154.80 Million	-24.40pp
2017-12-31	35.36%	CN¥300.00 Million ≈ $43.90 Million	CN¥848.31 Million ≈ $124.13 Million	+10.83pp
2016-12-31	24.54%	CN¥171.00 Million ≈ $25.02 Million	CN¥696.89 Million ≈ $101.98 Million	+8.18pp
2015-12-31	16.35%	CN¥100.00 Million ≈ $14.63 Million	CN¥611.49 Million ≈ $89.48 Million	+5.06pp
2014-12-31	11.29%	CN¥60.00 Million ≈ $8.78 Million	CN¥531.31 Million ≈ $77.75 Million	--

pp = percentage points

About Zhejiang Wolwo Bio-Pharmaceutical Co Ltd

SHE:300357 China Drug Manufacturers - General

Market Cap

$1.49 Billion

CN¥10.18 Billion CNY

Market Cap Rank

#7300 Global

#1569 in China

Share Price

CN¥19.45

Change (1 day)

+1.04%

52-Week Range

CN¥18.92 - CN¥35.30

All Time High

CN¥5101.55